- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02546063
Carbohydrate Estimation Supported by the GoCARB System
Carbohydrate Estimation Supported by the GoCARB System in Individuals With Type 1 Diabetes
The standard method for determining the carbohydrate content of a meal in patients with diabetes mellitus is the weighing of individual foods. However, in daily life, the weighing is not practical at all times. Inaccurate estimation of meal's CHO content, leads to wrong insulin doses and consequently to poor postprandial glucose control. Fact is that even well trained diabetic individuals find it difficult to estimate CHO precisely and that especially meals served on a plate are prone to false estimations underlining an emergent need for novel approaches to CHO estimation.
GoCarb is a computer vision-based system for calculating the carbohydrate content of meals. In a typical scenario, the user places a credit card-sized reference object next to the meal and acquires two images using his/her smartphone. A series of computer vision modules follows: the plate is detected and the different food items on the plate are automatically segmented and recognized, while their 3D shape is reconstructed. On the basis of the shape, the segmentation results and the reference card, the volume of each item is then estimated. The CHO content is calculated by combining the food types with its volumes, and by using the USDA nutritional database. Finally, the results are displayed to the user.
A preclinical study using the GoCarb system indicates that the system is able to estimate the meal's CHO content with higher accuracy than individuals with T1D. Furthermore, the feedback gathered by the participants showed that the system is easy to use even for non-smartphone users.
The aim of this randomized, cross-over pilot study is to investigate the benefits of an automated determination of the carbohydrate content of meals on glycemic control in subjects with type 1 diabetes mellitus with sensor-augmented insulin pump therapy.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background
For individuals with type 1 diabetes (T1D) the current gold standard to evaluate the carbohydrate (CHO) amount of a meal is by carefully weighing its different components and calculating the CHO content using reference nutritional tables. The resulting CHO amount is then used to define the insulin dose needed to avoid an abnormal postprandial glucose profile. Since this is a cumbersome procedure in real life, diabetic individuals often estimate the CHO amount based on their personal experience. Especially for food served on a plate CHO estimates are often significantly over or underestimated leading to high variation in postprandial blood glucose. Besides the immediate risk of hypoglycaemia, there is emerging evidence that suboptimal control of postprandial glucose is affiliated with increased risk for long-term complications (e.g. diabetic micro- and macro-vascular diseases).
The effect of CHO counting in T1D control has been increasingly recognized and investigated. A meta-analysis including five studies on individuals with T1D has shown, that improved CHO counting accuracy reduces the HbA1c significantly (0.64% reduction in HbA1c compared to a control group). Teaching adult individuals with T1D to count CHO reduces HbA1c significantly and also leads to an improvement in quality of life. Similar findings are reported in children, in whom higher CHO counting accuracy is associated with a lower HbA1c. Even a short educational intervention of 4 weeks can still result in a significant and sustained effect on HbA1c reduction 9 months after without having an increase in hypoglycaemia. Lower CHO counting accuracy is a significant predictor of prolonged time in hyperglycaemic state. In one study with adults only 31% of the participants estimated the CHO content with an error of less than 20 grams per day and accurate CHO estimation were correlated with the lowest HbA1c values. In line with these findings another study has shown that individuals on intensive insulin therapy count CHO content of meals with an average error in the order of 16 grams or 21%. In general there is overestimation of small meals and a substantial underestimation of large meals. While breakfast (+8.5%) and snacks (-5%) were estimated fairly accurately, lunch (-28%) and dinner (-23%) are more prone to errors leading to an underestimation in the order of 30 grams. In children, an inaccuracy of ±10grams does not deteriorate the postprandial glycaemic control, whereas a ±20 grams variation significantly impacts the postprandial glycaemia.
The debate how to optimally estimate CHO intake is on-going and controversial. Fact is that even well trained diabetic individuals find it difficult to estimate CHO precisely and that especially meals served on a plate are prone to false estimations underlining an emergent need for novel approaches to CHO estimation. The investigators hypothesize that computer vision supported CHO estimation can have a beneficial impact on postprandial glucose control, ultimately leading to reduced episodes of hypoglycaemia and reduction in long term complications.
The recent advances in smartphone technologies and computer vision permitted the development of applications for the automatic dietary assessment through meal image analysis. The applications are using either a number of images or a short video of the upcoming meal, as captured by the user's smartphone. Although several systems have been proposed in the past decade, none of them is designed for individuals with diabetes, while they rely on strong assumptions, which often do not hold in real life, or require too much user input. The GoCARB system provides CHO estimations to individuals with T1D, by using only two meal images. The current version GoCARB has been designed to deal with
- elliptical plates with a flat base;
- single-dish images;
- fully visible food items. The system works without assumptions on the food shape, while it supports the following food classes: Pasta, green salad, meat, breaded food, beans, carrots, mashed potato, rice, potatoes, bread, cheese, egg, couscous, mushrooms and spätzli.
Objective
The purpose of this study is to investigate the effect of GoCARB-supported CHO estimation in the postprandial glucose control of individuals with T1D on sensor augmented insulin pump therapy.
In a typical scenario, the user places a credit card-sized reference object next to the meal and acquires two images using her/his smartphone. A graphical user interface guides the user in choosing the optimal angles for image acquisition based on the smartphone's built-in sensors. The images are then transmitted to a dedicated server via Wi-Fi or the mobile network. Then, the following computer vision algorithms are activated: the plate is detected and the different food items on the plate are automatically segmented and recognized, while their 3D shape is reconstructed. On the basis of the shape, the segmentation results and the reference card, the volume and CHO content of each item is then calculated by combining the food types with its volumes. Finally, the results are displayed to the user.
Methods
This study's overall objective is to perform a prospective randomized controlled clinical pilot study comparing postprandial glucose control assisted by the GoCARB system against the usual care approach by the participants. Scope of the study will be to investigate whether the postprandial glucose profile is improved by using the GoCARB prototype for CHO estimation. Postprandial glycaemia is evaluated using continuous glucose monitoring.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bern, Switzerland, 3010
- Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Type 1 diabetes
- Minimum age of 18 years old
- Sensor-augmented pump therapy for at least six months
- HbA1c levels within the last 4 months ≤ 8.5%
- Familiar with carbohydrate (CHO) counting (e.g. CHO counting training in the past)
- Normal insulin sensitivity (reflected by a daily insulin requirement of 0.3-1.0 U/kg body weight)
- Able to comprehend German or English
- Written informed consent
Exclusion Criteria
- Relevant diabetic complications
- Hypoglycemia unawareness
- More than one episode of severe hypoglycemia as defined by American Diabetes Association in preceding 12 months
- Pregnancy
- Relevant psychiatric disorder
- Active neoplasia
- Participation in another study
- Other individuals especially in need of protection (according to the guidelines of the Swiss Academy of Medical Sciences)
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: GoCARB app
Smartphone app
|
The GoCARB system is a smartphone application designed to support type 1 diabetic patients with carbohydrate counting by providing automatic, accurate and near real-time CHO estimation for non-packed foods.
|
No Intervention: Conventional carbohydrate estimating methods
Individual usual carbohydrate estimation methods (weighing, experience, carbohydrate exchange tables etc.).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Average of the postprandial area under the glucose curve (AUC) measured over three hours after each meal's start using Continuous Glucose Monitoring
Time Frame: 14 days
|
14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Composite of insulin-related parameters
Time Frame: 14 days
|
Calculated from daily bolus, basal and correction insulin
|
14 days
|
Glucose-related parameters
Time Frame: 14 days
|
Postprandial glucose levels within, below and above target
|
14 days
|
Daily nutritional behavior in individuals with T1D
Time Frame: 14 days
|
Measured in kcal and documented by photographs
|
14 days
|
User satisfaction
Time Frame: 14 days
|
Composite measured by questionnaire: Participants will be invited to complete three questionnaires: i) a carbohydrate counting specific questionnaire including questions concerning educational level and former training of carbohydrate counting, and ii) a questionnaire related to GoCARB's features.
|
14 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Christoph Stettler, Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital
- Principal Investigator: Stavroula Mougiakakou, Diabetes Technology Research Group, ARTORG Center for Biomedical Engineering Research, University of Bern
- Principal Investigator: Markus Laimer, Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital
Publications and helpful links
General Publications
- Anthimopoulos MM, Gianola L, Scarnato L, Diem P, Mougiakakou SG. A food recognition system for diabetic patients based on an optimized bag-of-features model. IEEE J Biomed Health Inform. 2014 Jul;18(4):1261-71. doi: 10.1109/JBHI.2014.2308928.
- Agianniotis A, Anthimopoulos M, Daskalaki E, Drapela A, Stettler C, Diem P, Mougiakakou S. GoCARB in the Context of an Artificial Pancreas. J Diabetes Sci Technol. 2015 May;9(3):549-55. doi: 10.1177/1932296815583333. Epub 2015 Apr 21.
- Anthimopoulos M, Dehais J, Shevchik S, Ransford BH, Duke D, Diem P, Mougiakakou S. Computer vision-based carbohydrate estimation for type 1 patients with diabetes using smartphones. J Diabetes Sci Technol. 2015 May;9(3):507-15. doi: 10.1177/1932296815580159. Epub 2015 Apr 16.
- Bally L, Dehais J, Nakas CT, Anthimopoulos M, Laimer M, Rhyner D, Rosenberg G, Zueger T, Diem P, Mougiakakou S, Stettler C. Carbohydrate Estimation Supported by the GoCARB System in Individuals With Type 1 Diabetes: A Randomized Prospective Pilot Study. Diabetes Care. 2017 Feb;40(2):e6-e7. doi: 10.2337/dc16-2173. Epub 2016 Nov 29. No abstract available.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 100/15
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 1
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of California, San FranciscoJuvenile Diabetes Research FoundationCompletedType 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMUnited States, Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
Spiden AGDCB Research AGRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With HyperglycemiaSwitzerland
-
Hoffmann-La RocheRoche DiagnosticsCompletedDiabetes Mellitus Type 2, Diabetes Mellitus Type 1Germany
Clinical Trials on Smartphone App
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMalignant Solid Neoplasm | Sarcoma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Central Nervous System NeoplasmUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; American...RecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Population Health Research InstituteUniversity of British Columbia; Canadian Institutes of Health Research (CIHR); Childhood Obesity Foundation and other collaboratorsActive, not recruiting
-
University of WashingtonCompletedDepression | AnxietyUnited States
-
NYU Langone HealthNational Institutes of Health (NIH)Recruiting
-
World BankDepartment for International Development, United Kingdom; Wits Reproductive... and other collaboratorsCompletedHIV Infections | Antiretroviral Therapy | Patient Compliance | Viral Load | Cell PhoneSouth Africa
-
Hartford HospitalNational Institute of Mental Health (NIMH); Oui Therapeutics, Inc.CompletedSuicidal Ideation | Suicide, AttemptedUnited States
-
Oxford University Hospitals NHS TrustUniversity of OxfordCompletedPulmonary HypertensionUnited Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institute on Drug Abuse (NIDA)Recruiting
-
Assuta Medical CenterAriel UniversityUnknownBariatric Surgery Candidate | Nutritional and Metabolic DiseasesIsrael